Trexquant Investment LP Cytosorbents Corp Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $106,858 - $149,056	-12,984 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$7.65 - $8.98 $7,282 - $8,548	952 Added 7.91%	12,984 $103,000
Q3 2020 Nov 06, 2020	SELL	$7.37 - $11.54 $121,229 - $189,821	-16,449 Reduced 57.75%	12,032 $96,000
Q2 2020 Aug 07, 2020	BUY	$6.28 - $10.59 $178,860 - $301,613	28,481 New	28,481 $282,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.